CD4 and cancer: In anti-tumor immunity, CD8+ T cells have been considered as the main effector cells to destroy cancer targets, whereas the role of CD4+ T cells has been considered to be as helper of induction and maintenance of CD8+ T cells, as well as other immune cells such as antigen-presenting cells and B cells.